Document is current

Any future updates will be listed below

Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenström’s macroglobulinemia

Crossref DOI link: https://doi.org/10.1007/s00277-015-2516-7

Published Online: 2015-10-03

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark